Answers are grounded in this paper and cite their sources.
Dolutegravir HIV drug resistance (HIVDR) data from Africa remain sparse. We reviewed HIVDR results of Malawians on dolutegravir-based antiretroviral therapy (November 2020-September 2021). Of 6462 eligible clients, 33 samples were submitted to South Africa, 27 were sequenced successfully, and 8 (30%) had dolutegravir HIVDR. Malawi urgently requires adequate HIVDR testing capacity.
No takes yet. Share an insight, caveat, or question.
Oosterhout et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: